SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-235217
Filing Date
2017-07-26
Accepted
2017-07-25 17:51:05
Documents
7
Period of Report
2017-07-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d429334d8k.htm 8-K 20312
2 EX-1.1 d429334dex11.htm EX-1.1 188070
3 EX-5.1 d429334dex51.htm EX-5.1 6523
4 EX-99.1 d429334dex991.htm EX-99.1 7866
5 EX-99.2 d429334dex992.htm EX-99.2 7573
6 GRAPHIC g429334cm39.jpg GRAPHIC 2815
7 GRAPHIC g429334cm41.jpg GRAPHIC 2814
  Complete submission text file 0001193125-17-235217.txt   239835
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 17981278
SIC: 2834 Pharmaceutical Preparations